FHI vs VRTX · P/E 11, rev $981.7M vs P/E 30, rev $3.33B
Federated Investors Inc B (FHI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Federated Investors Inc B (FHI) is a asset management company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported FHI revenue for 2026-06-30 was $981.7M. Net income was $200.7M. FHI currently screens at market cap $4.33B and trailing P/E 11.1.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
FHI currently screens at market cap $4.33B and trailing P/E 11.1. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the FHI and VRTX stock pages for the full models.
Not investment advice.